Novartis this week became the fifth manufacturer to sue the Health Resources and Services Administration (HRSA) to implement a 340B [...] …
Blog Posts
Yesterday’s New York Times investigative article alleging that the 340B prime vendor, Apexus, profited by driving 340B program expansion has [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Lawmakers in Nebraska and New York have reintroduced 340B contract pharmacy access bills this week after their state legislatures failed [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
The evolving landscape of pharmaceutical pricing and reimbursement models presents complex challenges for manufacturers and pharmacies. One of the most significant developments is the introduction of the Inflation Reduction Act (IRA) and its Maximum Fair Price (MFP) provisions, aimed at reducing drug
…
The House Energy and Commerce (E&C) Committee, which has jurisdiction over the 340B and Medicaid programs, held its first meeting [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmakers Bristol Myers Squibb (BMS) and Vertex have each announced changes to their 340B contract pharmacy restrictions that apply to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Participation in the 340B program did not increase the number of vulnerable patients beginning targeted care for prostate cancer, a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Congress could pursue 340B program reform and spending cuts—along with other major health policy changes—as part of an expected budget [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The chairperson of a political action committee with multiple links to a conservative dark money group that ran controversial ads [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
It’s January, which means we’ve released our Top Ten Issues for 2025! The experts at Visante have provided insights into the most pressing issues and transformative opportunities in health system pharmacy for the
…